What are the risks of investing in MNPR?
M
What are the risks of investing in MNPR?
🦉
Monopar Therapeutics Inc. (MNPR)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOChandler D. Robinson
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the...
Key Executives
| Name | Title |
|---|---|
| Andrew J. Cittadine | Chief Operating Officer |
| Chandler D. Robinson | Co-Founder, Chief Executive Officer, President & Director |
| Christopher Starr | Co-Founder & Independent Executive Chairman of the Board |
| Patrice Rioux | Acting Chief Medical Officer |
| Quan Anh Vu | CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer |
| Susan Rodriguez | Chief Commercial & Strategy Officer |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A